Business Description
Burning Rock Biotech Ltd
ISIN : US12233L1070
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 30.14 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.2 | |||||
Beneish M-Score | -4.59 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.5 | |||||
3-Year EBITDA Growth Rate | 5.2 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | -2.1 | |||||
3-Year Book Growth Rate | -33.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.59 | |||||
9-Day RSI | 53.53 | |||||
14-Day RSI | 52.95 | |||||
6-1 Month Momentum % | -8.18 | |||||
12-1 Month Momentum % | -69.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.29 | |||||
Quick Ratio | 3.05 | |||||
Cash Ratio | 2.24 | |||||
Days Inventory | 188.14 | |||||
Days Sales Outstanding | 95.04 | |||||
Days Payable | 49.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 7.39 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.26 | |||||
Operating Margin % | -116.48 | |||||
Net Margin % | -113.27 | |||||
FCF Margin % | -35.15 | |||||
ROE % | -66.88 | |||||
ROA % | -49.11 | |||||
ROIC % | -158.8 | |||||
ROC (Joel Greenblatt) % | -305.51 | |||||
ROCE % | -65.36 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.01 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.74 | |||||
EV-to-EBIT | 0.04 | |||||
EV-to-EBITDA | 0.04 | |||||
EV-to-Revenue | -0.05 | |||||
EV-to-FCF | 0.14 | |||||
Price-to-Net-Current-Asset-Value | 0.92 | |||||
Price-to-Net-Cash | 1.73 | |||||
Earnings Yield (Greenblatt) % | 2500 | |||||
FCF Yield % | -34.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Burning Rock Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 66.83 | ||
EPS (TTM) (€) | -7.395 | ||
Beta | 0 | ||
Volatility % | 51.99 | ||
14-Day RSI | 52.95 | ||
14-Day ATR (€) | 0.111635 | ||
20-Day SMA (€) | 7.265 | ||
12-1 Month Momentum % | -69.33 | ||
52-Week Range (€) | 6.1 - 23.6 | ||
Shares Outstanding (Mil) | 10.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Burning Rock Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Burning Rock Biotech Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Burning Rock Biotech Ltd Frequently Asked Questions
What is Burning Rock Biotech Ltd(STU:6BU0)'s stock price today?
When is next earnings date of Burning Rock Biotech Ltd(STU:6BU0)?
Does Burning Rock Biotech Ltd(STU:6BU0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |